Proietto M, Crippa M, Damiani C, Pasquale V, Sacco E, Vanoni M, et al. Tumor heterogeneity: preclinical models, emerging technologies, and future applications. Front Oncol. 2023;28(13):1164535.

Google Scholar 

Sonugür FG, Akbulut H. The role of tumor microenvironment in genomic instability of malignant tumors. Front Genet. 2019;29(10):1063.

Google Scholar 

Palumbo A, de Oliveira Meireles Da Costa N, Bonamino MH, Ribeiro Pinto LF, Nasciutti LE. Genetic instability in the tumor microenvironment: a new look at an old neighbor. Mol Cancer. 2015;14:145.

PubMed  PubMed Central  Google Scholar 

Spaw M, Anant S, Thomas SM. Stromal contributions to the carcinogenic process. Mol Carcinog. 2017;56(4):1199–213.

CAS  PubMed  Google Scholar 

Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30(16):R921–5.

CAS  PubMed  PubMed Central  Google Scholar 

Neophytou CM, Panagi M, Stylianopoulos T, Papageorgis P. The role of tumor microenvironment in cancer metastasis: molecular mechanisms and therapeutic opportunities. Cancers. 2021;13(9):2053.

CAS  PubMed  PubMed Central  Google Scholar 

Brassart-Pasco S, Brézillon S, Brassart B, Ramont L, Oudart JB, Monboisse JC. Tumor microenvironment: extracellular matrix alterations influence tumor progression. Front Oncol. 2020;15(10):397.

Google Scholar 

Talmadge JE, Fidler IJ. AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res. 2010;70(14):5649–69.

CAS  PubMed  PubMed Central  Google Scholar 

Welch DR, Hurst DR. Defining the hallmarks of metastasis. Cancer Res. 2019;79(12):3011–27.

CAS  PubMed  PubMed Central  Google Scholar 

Seker-Polat F, Pinarbasi Degirmenci N, Solaroglu I, Bagci-Onder T. Tumor cell infiltration into the brain in glioblastoma: from mechanisms to clinical perspectives. Cancers. 2022;14(2):443.

CAS  PubMed  PubMed Central  Google Scholar 

Taiarol L, Formicola B, Fagioli S, Sierri G, D’Aloia A, Kravicz M, et al. The 3.0 cell communication: new insights in the usefulness of tunneling nanotubes for glioblastoma treatment. Cancers. 2021;13(16):4001.

CAS  PubMed  PubMed Central  Google Scholar 

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–96.

CAS  PubMed  Google Scholar 

Wilson TA, Karajannis MA, Harter DH. Glioblastoma multiforme: state of the art and future therapeutics. Surg Neurol Int. 2014;8(5):64.

Google Scholar 

Wagner J, Wickman E, DeRenzo C, Gottschalk S. CAR T cell therapy for solid tumors: bright future or dark reality? Mol Ther J Am Soc Gene Ther. 2020;28(11):2320–39.

CAS  Google Scholar 

Luksik AS, Yazigi E, Shah P, Jackson CM. CAR T cell therapy in glioblastoma: overcoming challenges related to antigen expression. Cancers. 2023;15(5):1414.

CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Zhang F, Xiong N, Xu H, Chai S, Wang H, et al. Remodelling and treatment of the blood-brain barrier in glioma. Cancer Manag Res. 2021;27(13):4217–32.

Google Scholar 

Sharma P, Aaroe A, Liang J, Puduvalli VK. Tumor microenvironment in glioblastoma: current and emerging concepts. Neuro-Oncol Adv. 2023;5(1):vdad009.

Google Scholar 

Tripathy DK, Panda LP, Biswal S, Barhwal K. Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches. Front Pharmacol. 2024. https://doi.org/10.3389/fphar.2024.1355242/full.

PubMed  PubMed Central  Google Scholar 

Mosteiro A, Pedrosa L, Ferrés A, Diao D, Sierra À, González JJ. The vascular microenvironment in glioblastoma: a comprehensive review. Biomedicines. 2022;10(6):1285.

CAS  PubMed  PubMed Central  Google Scholar 

Galvão RP, Zong H. Inflammation and gliomagenesis: bi-directional communication at early and late stages of tumor progression. Curr Pathobiol Rep. 2013;1(1):19–28.

PubMed  PubMed Central  Google Scholar 

McGettrick AF, O’Neill LAJ. The role of HIF in immunity and inflammation. Cell Metab. 2020;32(4):524–36.

CAS  PubMed  Google Scholar 

Yeo ECF, Brown MP, Gargett T, Ebert LM. The role of cytokines and chemokines in shaping the immune microenvironment of glioblastoma: implications for immunotherapy. Cells. 2021;10(3):607.

CAS  PubMed  PubMed Central  Google Scholar 

Alorfi NM, Ashour AM, Alharbi AS, Alshehri FS. Targeting inflammation in glioblastoma: an updated review from pathophysiology to novel therapeutic approaches. Medicine (Baltimore). 2024;103(21): e38245.

PubMed  Google Scholar 

Roesler R, Dini SA, Isolan GR. Neuroinflammation and immunoregulation in glioblastoma and brain metastases: recent developments in imaging approaches. Clin Exp Immunol. 2021;206(3):314–24.

CAS  PubMed  PubMed Central  Google Scholar 

Wakefield L. TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev. 2002;12(1):22–9.

CAS  PubMed  Google Scholar 

Seoane J, Gomis RR. TGF-β family signaling in tumor suppression and cancer progression. Cold Spring Harb Perspect Biol. 2017;9(12): a022277.

PubMed  PubMed Central  Google Scholar 

Sheikh KA, Amjad M, Irfan MT, Anjum S, Majeed T, Riaz MU, et al. Exploring TGF-β signaling in cancer progression: prospects and therapeutic strategies. OncoTargets Ther. 2025;18(18):233–62.

Google Scholar 

Kowanetz M, Valcourt U, Bergström R, Heldin CH, Moustakas A. ID2 and ID3 define the potency of cell proliferation and differentiation responses to transforming growth factor β and bone morphogenetic protein. Mol Cell Biol. 2004;24(10):4241–54.

CAS  PubMed  PubMed Central  Google Scholar 

Markowitz S. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev. 1996;7(1):93–102.

CAS  PubMed  Google Scholar 

Kim SJ, Im YH, Markowitz SD, Bang YJ. Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis. Cytokine Growth Factor Rev. 2000;11(1–2):159–68.

CAS  PubMed  Google Scholar 

Hao Y, Baker D, ten Dijke P. TGF-β-mediated epithelial–mesenchymal transition and cancer metastasis. Int J Mol Sci. 2019;20(11):2767.

CAS  PubMed  PubMed Central  Google Scholar 

Tsubakihara Y, Moustakas A. Epithelial–mesenchymal transition and metastasis under the control of transforming growth factor β. Int J Mol Sci. 2018;19(11):3672.

PubMed  PubMed Central  Google Scholar 

Yang XJ, Chen GL, Yu SC, Xu C, Xin YH, Li TT, et al. TGF-β1 enhances tumor-induced angiogenesis via JNK pathway and macrophage infiltration in an improved zebrafish embryo/xenograft glioma model. Int Immunopharmacol. 2013;15(2):191–8.

PubMed  Google Scholar 

Golán-Cancela I, Caja L. The TGF-β family in glioblastoma. Int J Mol Sci. 2024;25(2):1067.

PubMed  PubMed Central  Google Scholar 

Bruna A, Darken RS, Rojo F, Ocaña A, Peñuelas S, Arias A, et al. High TGFβ–SMAD activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell. 2007;11(2):147–60.

CAS  PubMed  Google Scholar 

Kjellman C, Olofsson SP, Hansson O, Von Schantz T, Lindvall M, Nilsson I, et al. Expression of TGF-β isoforms, TGF-β receptors, and SMAD molecules at different stages of human glioma. Int J Cancer. 2000;89(3):251–8.

CAS  PubMed  Google Scholar 

Gieryng A, Pszczolkowska D, Walentynowicz KA, Rajan WD, Kaminska B. Immune microenvironment of gliomas. Lab Invest. 2017;97(5):498–518.

CAS  PubMed  Google Scholar 

Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, et al. TGF-β: duality of function between tumor prevention and carcinogenesis. JNCI J Natl Cancer Inst. 2014;106(2):djt369.

PubMed  Google Scholar 

Irshad K, Srivastava C, Malik N, Arora M, Gupta Y, Goswami S, et al. Upregulation of atypical cadherin FAT1 promotes an immunosuppressive tumor microenvironment via TGF-β. Front Immunol. 2022. https://doi.org/10.3389/fimmu.2022.813888.

PubMed  PubMed Central  Google Scholar